Trends in Neurosciences
Desensitization of nicotinic ACh receptors: shaping cholinergic signaling
Introduction
Nicotinic ACh receptors (nAChRs) are ligand-gated ion channels assembled as pentamers of diverse subunits 1, 2. Usually, nAChRs are fast transducers of signals activated by the transmitter ACh, or by the drug of abuse nicotine 1, 2. Nevertheless, when ACh, nicotine or related agonists are continuously applied, nAChRs become ‘desensitized’ (i.e. temporarily inactive) 3, 4. Desensitization can therefore be seen as a use-dependent, readily reversible form of signal plasticity that might shape synaptic efficacy in various brain regions, or even protect cells from uncontrolled excitation 5, 6, 7, 8. Although the role of nAChR desensitization in normal cholinergic transmission remains unclear, its potential to control cholinergic activity and induce adaptive changes is considerable. In the short period of seconds to minutes, nAChR desensitization underlies the brief skeletal muscle paralysis caused by agents such as succinylcholine during general anesthesia [9]. Over a longer time-frame, nAChR desensitization might be important in understanding the therapeutic efficacy of various nicotinic drugs now used to treat the cholinergic dysfunction associated with neurodegenerative disease 10, 11. Furthermore, nAChR desensitization might even lead to chronic modulation of nAChRs in the brain of tobacco smokers 5, 6, 7. The aim of this review is to clarify the molecular mechanisms involved in nAChR desensitization, the compensatory changes triggered by it, the phenotypes resulting from its alteration, and new strategies for its modulation with the ultimate goal of fine-tuning cholinergic function in health and disease.
Section snippets
Desensitization depends on nAChR subunits
In the mammalian nervous system, nAChRs can be broadly classified as either α7-containing nAChRs that desensitize rapidly (in milliseconds) or non-α7 receptors that desensitize slowly (in seconds) and are made up of various combinations of α and β subunits 1, 2, 4. Among non-α7 receptors, the two most common subtypes are α3β4 (mainly expressed by autonomic neurons and moderately susceptible to desensitization) and α4β2 receptors (widely found in the brain and very prone to desensitization) [4] (
Desensitization kinetic properties
When a medium to high (μM to mM) concentration of agonist is applied, nAChRs are first activated and can then desensitize with subsequent recovery after agonist removal. This process will be referred to here as ‘classical desensitization’ (Figure 1; see Box 1a for kinetic scheme) that develops usually in the range of tens of milliseconds, although different subtypes of nAChRs have differential susceptibility to desensitization (Table 1). Furthermore, nicotine and ACh have differential ability
Agonist-specific recovery from desensitization
In the classical receptor model [3], the recovery from desensitization should be independent of the type of agonist used. Although the recovery from desensitization depends on the nAChR subtype [4], recent findings suggest a novel, agonist-specific rate of recovery for α7 [20], α3β4 [22], α4β2 [16] and muscle-type nAChRs [23]. When the onset and extent of desensitization are similar, the recovery of α4β2 receptors after the removal of nicotine requires much more time than recovery after the
Desensitization and agonist trapping
As originally considered by Katz and Thesleff [3], high affinity of desensitized receptors for agonist indicates that they might be potential traps for unbound agonist molecules 14, 15. Whereas non-α7 receptors possess two agonist-binding sites 24, 25, α7 receptors might theoretically contain up to five binding sites 21, 26, making them especially suited for trapping ACh. At neuromuscular junctions, the ‘trapping’ of released ACh by desensitized receptors can shorten the decay of cholinergic
Molecular determinants of desensitization
The structure of muscle-type nAChRs has been elucidated in electron-microscope studies, under conditions to minimize desensitization (<5 ms agonist application) [25]. Desensitized receptors show a structural transition in which the γ and δ subunits switch to a less-symmetrical configuration [27]. Although identification of the molecular structures underlying desensitization is still incomplete, site-directed mutagenesis within receptor subunits has revealed that replacement of certain elements
Modulation of desensitization
Desensitization is a plastic process, rapidly adapting to changes in neuronal activity through modulation by local factors. One of these is the endogenous peptide substance P, which powerfully facilitates desensitization by binding to an allosteric site distinct from the ACh-recognition sites [41]. Because substance P colocalizes with ACh in the splanchnic nerve terminals in the adrenal gland from which substance P is released in response to stress [41], this peptide might thus attenuate
nAChR desensitization at cholinergic synapses
In the mammalian CNS, excitatory cholinergic transmission mediated by either α7 or non-α7 nAChRs has been observed in GABAergic interneurons of the hippocampus [46], in hypothalamic supraoptic neurons [47], in developing visual cortex neurons [48], in Renshaw cells [49] and in deep interneurons in the spinal cord [50]. Whether the endogenous transmitter ACh can desensitize these receptors has not been systematically investigated. However, hypothalamic nAChRs show modest desensitization, even
nAChR desensitization controls the main action of brain nAChRs to facilitate transmitter release
Although postsynaptic nAChRs can mediate fast cholinergic transmission in the brain, historically nAChRs had been thought to act primarily by controlling the release of other neurotransmitters (e.g. glutamate, GABA and dopamine) from nerve terminals 55, 56, and in this way to regulate synaptic efficacy, synaptic plasticity and cognition, and also nicotine addiction 5, 6. Thus, nAChRs can be viewed as gain-setters of excitatory and inhibitory signals mediated by other transmitters. This effect
Epilepsy and seizures
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is a rare form of epilepsy characterized by brief seizures during the night [61]. Several mutations have been found in genes encoding the α4 and β2 neuronal nAChR subunits (although several affected families do not possess any mutations in these genes), many of which reside in or adjacent to M2 of these subunits. Although these mutations produce similar clinical symptoms [62], they have various effects on channel function, including a
Protean actions of nAChRs
The activation and/or regulation of nAChRs, particularly of those containing the α7 subunit, are paradoxically linked to both neuroprotection and neurotoxicity in vivo and in vitro. For example, the neuroprotective action of nicotine in cultured PC12 cells has been suggested to be due to upregulation of α7-containing nAChRs following their persistent desensitization [11]. Such neuroprotection might have clinical implications because some nicotinic ligands appear to minimize the cognitive
Concluding remarks
nAChR desensitization should represent a major target for the upregulation and/or downregulation of nAChR function. By exploiting its dependence on the nAChR subtype, it might be possible in the future to obtain differential regulation of cholinergic signals within the same circuit expressing heterogeneous nAChRs. Furthermore, because desensitization can occur even at agonist concentrations insufficient to activate receptors, it might be possible to minimize drug doses in the interest of safety.
Acknowledgements
This work was supported by PRIN and FIRB grants (to A.N.), by RFFI grants (to R.G.) and by the NIH Intramural program (J.Y.). We would like to thank C. Erxleben and S. Dudek for advice in preparing the manuscript.
References (75)
Synaptic plasticity and nicotine addiction
Neuron
(2001)The role of desensitisation in decay time of miniature endplate currents in frogs Rana ridibunda and Rana temporaria
Neurosci. Res.
(2001)- et al.
Nicotine addiction: the possible role of functional upregulation
Trends Pharmacol. Sci.
(2002) Choline and acetylcholine have similar kinetic properties of activation and desensitization on the α7 nicotinic receptors in rat hippocampal neurons
Brain Res.
(2000)α7 receptor-selective agonists and modes of α7 receptor activation
Eur. J. Pharmacol.
(2000)Structure and action of the nicotinic acetylcholine receptor explored by electron microscopy
FEBS Lett.
(2003)- et al.
Roles of agonist-binding sites in nicotinic acetylcholine receptor function
Biochem. Biophys. Res. Commun.
(2000) Mutation (Ser284Leu) of neuronal nicotinic acetylcholine receptor α4 subunit associated with frontal lobe epilepsy causes faster desensitization of the rat receptor expressed in oocytes
Epilepsy Res.
(2002)Nicotine-induced up-regulation and desensitization of α4β2 neuronal nicotinic receptors depend on subunit ratio
J. Biol. Chem.
(2004)Acetylcholine receptor extracellular domain determines sensitivity to nicotine-induced inactivation
Eur. J. Pharmacol.
(2000)
Co-expression of α7 and β2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons
Neuroscience
α-Bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices
Brain Res.
Presynaptic nicotinic ACh receptors
Trends Neurosci.
Nicotinic acetylcholine receptors and the regulation of neuronal signalling
Trends Pharmacol. Sci.
Nicotinic receptors in the brain: correlating physiology with function
Trends Neurosci.
The promise and pitfalls of a nicotinic cholinergic approach to pain management
Pain
Nicotine differentially activates inhibitory and excitatory neurons in the dorsal spinal cord
Pain
Genes and mutations in human idiopathic epilepsy
Brain Dev.
Neuronal nicotinic receptors: from structure to pathology
Prog. Neurobiol.
Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease
Behav. Brain Res.
Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonists
Neuropharmacology
Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
Annu. Rev. Physiol.
Nicotinic receptors at the amino acid level
Annu. Rev. Pharmacol. Toxicol.
A study of the ‘desensitization’ produced by acetylcholine at the motor end-plate
J. Physiol.
Desensitization of neuronal nicotinic receptors
J. Neurobiol.
Cellular and synaptic mechanisms of nicotine addiction
J. Neurobiol.
Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas
J. Neurosci.
Neurotoxicity of channel mutations in heterologously expressed α7-nicotinic acetylcholine receptors
Eur. J. Neurosci.
Synthesis and structure-activity relationships of neuromuscular blocking agents
Curr. Med. Chem.
How mutations in the nAChRs can cause ADNFLE epilepsy
Epilepsia
Relationship between the increased cell surface α7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists
J. Neurosci. Res.
Sleuthing molecular targets for neurological diseases at the neuromuscular junction
Nat. Rev. Neurosci.
Desensitization of mouse nicotinic acetylcholine receptor channels. A two-gate mechanism
J. Gen. Physiol.
Desensitization shortens the high-quantal-content endplate current time course in frog muscle with intact cholinesterase
J. Physiol.
Nicotine is highly effective at producing desensitization of rat α4β2 neuronal nicotinic receptors
J. Physiol.
Spontaneous openings of the acetylcholine receptor channel
Proc. Natl. Acad. Sci. U. S. A.
Desensitization of the acetylcholine receptor of frog end-plates measured in a vaseline-gap voltage clamp
J. Physiol.
Cited by (302)
Acute poisoning by chlorpyrifos differentially impacts survival and cardiorespiratory function in normotensive and hypertensive rats
2024, Chemico-Biological InteractionsNicotine use disorder and Neuregulin 3: Opportunities for precision medicine
2024, Advances in PharmacologyCholinergic modulation of circuits
2022, Neurocircuitry of AddictionRegulatory effects of nicotine on neurite outgrowth in rat superior cervical ganglia cells
2022, Journal of Pharmacological Sciences